Description

The ProdromeScan blood test measures hundreds of biomarkers and key biochemical systems critical for optimal health.
The biomarkers are scientifically linked to risk of diseases including Alzheimer’s, Parkinson’s, multiple sclerosis, cancers, heart disease, and diabetes.
Prodrome Sciences (PSI) has refined untargeted metabolomics to reduce the error in the measurement of hundreds and potentially thousands of metabolites. PSI has opened up the powerful data generating capabilities of this technology to OpenCures in the form of the Prodrome-R (RESEARCH-ONLY) assay. PSI ensures that the data is accurate while OpenCures formats the results to help the self-directed researcher interpret the results for their own use giving them unparalleled insight into their biomolecular health at resolutions never before possible. Moreover, PSI is continuously expanding the number of metabolites measured by Prodrome-R, so researchers who have used Prodrome-R will benefit from ongoing discoveries if they choose to share their data for research purposes.